A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone (Q28217765)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 15 February 2005)
edit
Language Label Description Also known as
English
A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone
scientific article (publication date: 15 February 2005)

    Statements

    A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone (English)
    0 references
    0 references
    Mark D Schleinitz
    0 references
    15 February 2005
    0 references
    142
    0 references
    4
    0 references
    251-9
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit